Results 1 to 10 of about 87,451 (257)
Renal potassium wasting from hydroxychloroquine at therapeutic doses: a case report [PDF]
BMC NephrologyBackground Hydroxychloroquine is a common disease-modifying treatment for systemic autoimmune disease and is usually well-tolerated. In acute hydroxychloroquine or chloroquine toxicity, hypokalemia typically reflects a transient intracellular potassium ...
Justin David Tse, Sourabh Kharait
doaj +2 more sources
Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019 [PDF]
The Korean Journal of Internal Medicine, 2021 Background/Aims The efficacies of lopinavir-ritonavir or hydroxychloroquine remain to be determined in patients with coronavirus disease 2019 (COVID-19).
Ji-Won Kim +6 more
doaj +1 more source
PLoS ONE, 2021 BackgroundHydroxychloroquine is not efficacious as post-exposure prophylaxis against coronavirus disease 2019 (COVID-19). It is not known whether as pre-exposure prophylaxis it may prevent COVID-19.ObjectiveTo compare the incidence of COVID-19 in Spanish
Juan Macías +11 more
doaj +1 more source
New Benefits of Hydroxychloroquine in Pregnant Women with Systemic Lupus Erythematosus: A Retrospective Study in a Tertiary Centre [PDF]
Revista Brasileira de Ginecologia e Obstetrícia, 2020 Objective: To determine pregnancy outcomes in women with systemic lupus erythematosus (SLE) who were treated with hydroxychloroquine in a tertiary center.
Rahana Abd Rahman +5 more
doaj +1 more source
Hydroxychloroquine-induced Retinal Toxicity
Frontiers in Pharmacology, 2023 Long-term use of hydroxychloroquine can cause retinopathy, which may result in severe and progressive visual loss. In the past decade, hydroxychloroquine use has markedly increased and modern retinal imaging techniques have enabled the detection of early,
Imran H. Yusuf +2 more
doaj +1 more source
The mechanism of chloroquine/hydroxychloroquine and its application in stomatological diseases
口腔疾病防治, 2021 Chloroquine and hydroxychloroquine are both classic 4-aminoquinoline antimalarial drugs with similar chemical structures and mechanisms of action.
LIN Lin, WU Kaihui, WANG Wenmei
doaj +1 more source
Hydroxychloroquine retinopathy [PDF]
Eye, 2017 Hydroxychloroquine (HCQ; Plaquenil) is used increasingly in the management of a variety of autoimmune disorders, with well established roles in dermatology and rheumatology and emerging roles in oncology. Hydroxychloroquine has demonstrated a survival benefit in patients with systemic lupus erythematosus; some clinicians advocate its use in all such ...
Yusuf, I +3 more
openaire +2 more sources
Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy
Arthritis & Rheumatology, 2020 ObjectiveIn 2016, the American Academy of Ophthalmology (AAO) changed the recommended daily dose of hydroxychloroquine (HCQ) from 6.5 mg/kg to <5 mg/kg. However, it is not clear that the lower prescribed dose of HCQ will have the same efficacy for systemic lupus erythematosus (SLE) activity or the same role in protecting against cardiovascular risk ...
Michelle Petri +4 more
openaire +3 more sources
Hyperpigmentation Induced by Hydroxychloroquine: A Case Report [PDF]
Journal of Clinical and Diagnostic Research, 2019 Hydroxychloroquine is an antimalarial drug which is widely used in the treatment of rheumatoid arthritis, owing to its immunosuppressive and anti-inflammatory properties.
Bhanukumar Muthaiah +2 more
doaj +1 more source
Unmet needs and future perspectives in hydroxychloroquine retinopathy
Frontiers in Medicine, 2023 Retinopathy is a well-recognized toxic effect of hydroxychloroquine treatment. As hydroxychloroquine retinopathy is potentially a vision-threatening condition, early detection is imperative to minimize vision loss due to drug toxicity.
Imran H. Yusuf +2 more
doaj +1 more source